Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Search
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)
Hang Seng
17,778.41
(0.22%)
Dow Jones
40,665.02
(-1.29%)
Nikkei 225
40,126.35
(-2.36%)
FTSE 100
8,204.89
(0.21%)
USD/AUD
0.6767
(-0.28%)
Bitcoin
64,872.44
(-0.79%)
Oil
82.22
(-0.72%)
Gold
2,440.70
(-0.64%)
Lithium
41.42
(1.37%)
Iron Ore
104.8
(-0.65%)

Island Pharmaceuticals (ASX: $ILA) progresses ISLA-101 study and secures key patent

Island Pharmaceuticals (ASX: $ILA) Q2 FY24 Activities Overview


Island Pharmaceuticals Ltd (ASX: $ILA) has reported its quarterly business activities for the three-month period ended 31 December 2023. The company completed dosing cohorts 1 and 2 in its ISLA-101 Single Ascending Dose study, with the third cohort dosed under fasted conditions. Additionally, Island received a tax refund of $386,345 for FY2023 and secured a facility with Radium Capital for prepayment of forecast R&D Tax Incentive. The company closed the quarter with a cash position of $1.0m.

Executive Commentary on Q2 FY24 Progress


CEO of Island Pharmaceuticals, Dr David Foster, stated, 'We made significant progress this quarter, with the first two cohorts of our ISLA-101 Single Ascending Dose study completed, and the first dose provided to our third cohort. Data read-outs are on track for early 2024, which will help optimize our planned Phase 2a PEACH clinical trial. Our loan agreement with Radium Capital provided an important form of non-dilutive funding to support the progress of ISLA-101 development, while our ISLA-101 intellectual property portfolio was further boosted with the granting of a key Australian patent.'

Summary of Quarterly Report and Outlook


Island Pharmaceuticals (ASX: $ILA) made significant advancements in its ISLA-101 Single Ascending Dose study during Q2 FY24. The company completed dosing cohorts 1 and 2, with the third cohort dosed under fasted conditions. Additionally, Island secured a key patent from IP Australia covering the method of treating or preventing flavivirus infections by administering ISLA-101. The company also received a tax refund for FY2023 and secured a facility with Radium Capital for prepayment of forecast R&D Tax Incentive. Island's cash position at the end of the quarter was $1.0m. Looking ahead, the data read-outs expected in early 2024 will be crucial in optimizing the planned Phase 2a PEACH clinical trial. Island's progress in securing non-dilutive funding and enhancing its intellectual property portfolio bodes well for the future development of ISLA-101 in addressing infectious diseases.

Sourcehttps://announcements.asx.com.au/asxpdf/20240131/pdf/05zxdht1xnx2fj.pdf

Share to Social
0 Comments
Inline Feedbacks
View all comments

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions